Costas Karatzas
Founder at Acesis BioMed US, Inc.
Net worth: 103 $ as of 2017-08-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard M. Schell | M | 67 |
Acesis BioMed US, Inc.
 Acesis BioMed US, Inc. Pharmaceuticals: MajorHealth Technology IASO BioMed, Inc. operates as a developmental stage biotechnology company. It focuses on researching and developing a drug. The company founded on March 11, 2015 and is headquartered in Centennial, CO. | 9 years |
| Vassilios Papadopoulos | M | 63 |
Acesis BioMed US, Inc.
Acesis BioMed US, Inc. Pharmaceuticals: MajorHealth Technology IASO BioMed, Inc. operates as a developmental stage biotechnology company. It focuses on researching and developing a drug. The company founded on March 11, 2015 and is headquartered in Centennial, CO. | 9 years |
| Duane Knight | M | 64 |
Acesis BioMed US, Inc.
Acesis BioMed US, Inc. Pharmaceuticals: MajorHealth Technology IASO BioMed, Inc. operates as a developmental stage biotechnology company. It focuses on researching and developing a drug. The company founded on March 11, 2015 and is headquartered in Centennial, CO. | 7 years |
| Barry Zirkin | M | - |
Acesis BioMed US, Inc.
Acesis BioMed US, Inc. Pharmaceuticals: MajorHealth Technology IASO BioMed, Inc. operates as a developmental stage biotechnology company. It focuses on researching and developing a drug. The company founded on March 11, 2015 and is headquartered in Centennial, CO. | - |
| Thomas Olson | M | 58 |
Acesis BioMed US, Inc.
Acesis BioMed US, Inc. Pharmaceuticals: MajorHealth Technology IASO BioMed, Inc. operates as a developmental stage biotechnology company. It focuses on researching and developing a drug. The company founded on March 11, 2015 and is headquartered in Centennial, CO. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 5 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Costas Karatzas
- Personal Network
